McSally Leads Bicameral Letter to Incentivize Investment in Valley Fever Drug and Vaccine Development
July 26, 2019
July 26, 2019
WASHINGTON, July 26 -- Sen. Martha McSally, R-Arizona, issued the following news release:
Today, Senator Martha McSally (R-AZ) led a bicameral letter to Secretary of Health and Human Services (HHS) Alex Azar and Acting Commissioner of the U.S. Food and Drug Administration (FDA) Dr. Norman Sharpless requesting the inclusion of Coccidioidomycosis, commonly referred to as Valley Fever, in the FDA's Tropical Disease Priority Review Voucher (PRV) Program. U.S. Senator John Cornyn (R-TX) . . .
Today, Senator Martha McSally (R-AZ) led a bicameral letter to Secretary of Health and Human Services (HHS) Alex Azar and Acting Commissioner of the U.S. Food and Drug Administration (FDA) Dr. Norman Sharpless requesting the inclusion of Coccidioidomycosis, commonly referred to as Valley Fever, in the FDA's Tropical Disease Priority Review Voucher (PRV) Program. U.S. Senator John Cornyn (R-TX) . . .